Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19059730 | ELECTROMAGNETIC DEVICE AND METHOD FOR TREATING CANCERS AND TUMORS | February 2025 | January 2026 | Abandon | 11 | 1 | 0 | No | No |
| 19051875 | NECK FAN | February 2025 | September 2025 | Allow | 8 | 1 | 0 | No | No |
| 17926425 | DEVICE FOR DIAGNOSING AND TREATING OCULAR DEVIATION | November 2022 | January 2026 | Abandon | 38 | 1 | 0 | No | No |
| 17981413 | BOO BOO PAK | November 2022 | February 2026 | Abandon | 40 | 1 | 0 | No | No |
| 17782553 | Method and Device for Reproducible Placement of ECG Chest Electrodes | June 2022 | June 2025 | Allow | 37 | 0 | 0 | No | No |
| 17552954 | BIOCOMPATIBLE AND ELECTROCONDUCTIVE POLYMERIC MICRONEEDLE BIOSENSOR FOR MINIMALLY INVASIVE BIOSENSING | December 2021 | July 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17512797 | DEFORMABLE THERMAL PACK | October 2021 | October 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17498976 | Multi-lumen Probe | October 2021 | August 2025 | Allow | 47 | 4 | 0 | Yes | No |
| 17499266 | Methods and systems for treatment of skin of a subject | October 2021 | July 2025 | Allow | 45 | 2 | 0 | No | No |
| 17495787 | FLEXIBLE COLD/HOT COMPRESS STRIP | October 2021 | October 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17489894 | ELECTROSURGICAL INSTRUMENT WITH FIBER OPTIC ROTARY COUPLING | September 2021 | March 2026 | Abandon | 53 | 3 | 1 | Yes | No |
| 17598712 | MICROWAVE APPARATUS AND METHOD | September 2021 | May 2025 | Abandon | 44 | 1 | 1 | No | No |
| 17480733 | SURGICAL INSTRUMENT | September 2021 | November 2025 | Abandon | 50 | 4 | 1 | No | No |
| 17472487 | Staggered Pairs of Biased Ablation Electrodes on Basket Catheter | September 2021 | June 2025 | Allow | 45 | 4 | 0 | Yes | No |
| 17459638 | SYSTEM AND RELATED METHOD FOR DECREASING SYMPTOMS OF PRIMARY DYSMENORRHEA OF A PERSON | August 2021 | March 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17407637 | MULTIFUNCTIONAL SURGICAL TOOL AND SYSTEM | August 2021 | February 2026 | Abandon | 53 | 4 | 1 | No | No |
| 17362516 | WEARABLE APPARATUS AND DRY ELECTRODE FOR ACQUIRING ELECTROPHYSIOLOGICAL SIGNALS AS WELL AS METHOD FOR PRODUCING THE SAME | June 2021 | March 2025 | Abandon | 45 | 2 | 1 | No | No |
| 17418885 | PROBE FOR IMPLANTATION INTO NERVOUS TISSUE COMPRISING A MICROELECTRODE OR A SET OF MICROELECTRODES | June 2021 | July 2025 | Allow | 49 | 2 | 1 | No | No |
| 17304102 | MEDICAL SYSTEM AND METHOD OF USE | June 2021 | May 2024 | Abandon | 35 | 4 | 0 | Yes | No |
| 17330375 | COMPOSITE BIOELECTRODES | May 2021 | October 2025 | Abandon | 53 | 2 | 1 | No | No |
| 17296685 | HERMETIC PACKAGING OF ELECTRONIC COMPONENTS | May 2021 | December 2025 | Abandon | 54 | 3 | 0 | Yes | No |
| 17246022 | INTERCHANGEABLE END EFFECTOR RELOADS | April 2021 | November 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17246141 | SHAFT SYSTEM FOR SURGICAL INSTRUMENT | April 2021 | November 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17240356 | TREATMENT APPARATUS | April 2021 | March 2025 | Abandon | 47 | 3 | 0 | No | No |
| 17285923 | BIOMEDICAL ELECTRODE, BIOMEDICAL SENSOR, AND BIOMEDICAL SIGNAL MEASUREMENT SYSTEM | April 2021 | February 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17233402 | Haptic Healthcare Patient Garment | April 2021 | July 2025 | Allow | 51 | 3 | 1 | Yes | No |
| 17265411 | ORAL COOLING DEVICE UTILIZING COOLING BALLOON | February 2021 | May 2025 | Allow | 51 | 4 | 0 | No | No |
| 17263971 | A Health Promoting Device | January 2021 | August 2025 | Abandon | 55 | 3 | 0 | No | No |
| 17096061 | DEVICE FOR TREATING ENDOMETRIOSIS | November 2020 | March 2026 | Allow | 60 | 6 | 1 | No | No |
| 16098723 | ELECTROSURGICAL DEVICE WITH INTEGRATED MICROWAVE SOURCE | November 2018 | July 2025 | Abandon | 60 | 8 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner KERN, ASHLEIGH LAUREN works in Art Unit 3794 and has examined 25 patent applications in our dataset. With an allowance rate of 28.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 47 months.
Examiner KERN, ASHLEIGH LAUREN's allowance rate of 28.0% places them in the 4% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by KERN, ASHLEIGH LAUREN receive 2.84 office actions before reaching final disposition. This places the examiner in the 83% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by KERN, ASHLEIGH LAUREN is 47 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +20.6% benefit to allowance rate for applications examined by KERN, ASHLEIGH LAUREN. This interview benefit is in the 64% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 15.9% of applications are subsequently allowed. This success rate is in the 12% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.